Home NDC 67877-256-45 NDC 67877-256-45 - Lanthanum Carbonate This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 67877-256
Requested NDC 67877-256-45
Package NDCs from labels 67877-256-45, 67877-256-90
Manufacturer Ascend Laboratories, LLC | Alkem Laboratories Limited
Effective date 2025-05-06
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67877-256-45 Lanthanum Carbonate 45 in 1 BOTTLE TABLET, CHEWABLE 45 15 67877-256-90 Lanthanum Carbonate 2 in 1 CARTON TABLET, CHEWABLE 2 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67877-256 LANTHANUM CARBONATE TABLET, CHEWABLE [ASCEND LABORATORIES, LLC] 15 Current NDC, 2 package rows 20250511_22b07167-2b7b-42ba-9ae9-cf58c98a2ab2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 7 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lanthanum carbonate LANTHANUM CARBONATE Prasco Laboratories bb263fe8-2bdf-4dba-807f-194f54a73654 2025-12-15 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T Lanthanum Carbonate LANTHANUM CARBONATE Ascend Laboratories, LLC 22b07167-2b7b-42ba-9ae9-cf58c98a2ab2 2025-05-06 Warnings, Adverse reactions Exact identifier application number: ANDA202329 ndc (package): 67877-257-15 ndc (package): 67877-258-90 ndc (package): 67877-256-90 ndc (package): 67877-258-11 ndc (package): 67877-256-45 ndc (package): 67877-257-90 ndc (product): 67877-258 ndc (product): 67877-257 ndc (product): 67877-256 ndc11 (package): 67877025645 rxcui: 477347 rxcui: 602635 rxcui: 642452 spl id: ba371296-8731-4ffa-ab36-aff022e48d52 spl set id: 22b07167-2b7b-42ba-9ae9-cf58c98a2ab2 unii: 490D9F069T Lanthanum carbonate LANTHANUM CARBONATE Teva Pharmaceuticals USA, Inc. e4b88992-ecb0-455b-b68c-5c4e6d3cf521 2025-01-30 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T Fosrenol LANTHANUM CARBONATE Takeda Pharmaceuticals America, Inc. f10776b2-2c25-4343-aabe-68f302e5cb54 2024-12-31 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T Lanthanum Carbonate LANTHANUM CARBONATE Lupin Pharmaceuticals, Inc. 91556a42-5e16-4f86-bae9-a8cdd6b182a6 2024-11-07 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T Lanthanum carbonate LANTHANUM CARBONATE Cipla USA Inc. 1d5ff930-1189-4e96-bdfb-9fd9c2c83d1b 2024-08-01 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T Lanthanum carbonate LANTHANUM CARBONATE Exelan Pharmaceuticals, Inc. 16b0e6f5-4fc9-448c-994a-cb9dd8b03654 2024-08-01 Warnings, Adverse reactions Exact identifier rxcui: 477347 rxcui: 602635 rxcui: 642452 unii: 490D9F069T
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.